Adverse Audio-Vestibular Effects of Drugs and Vaccines Used in the Treatment and Prevention of COVID-19: A Review
(1) Background: The purpose of this article is to review pharmacological treatments for COVID-19 (currently approved by the EMA (European Medical Agency) and FDA (Food and Drug Administration)) and highlight their potential audio-vestibular side-effects as an ototoxic adverse reaction. (2) Methods:...
Main Authors: | Magdalena B. Skarzynska, Monika Matusiak, Piotr H. Skarzynski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Audiology Research |
Subjects: | |
Online Access: | https://www.mdpi.com/2039-4349/12/3/25 |
Similar Items
-
The Ototoxicity of Antimalarial Drugs—A State of the Art Review
by: Magdalena Jozefowicz-Korczynska, et al.
Published: (2021-04-01) -
COVID-19 and cochleovestibular disorders: A review
by: Andrey Yu. Ovchinnikov, et al.
Published: (2023-06-01) -
Otologic and vestibular symptoms in COVID‐19: A scoping review
by: Kimberly Mae C. Ong, et al.
Published: (2022-12-01) -
Audio-Vestibular Manifestations in COVID-19; A Systematic Review and Meta-analysis
by: Saikat Samaddar, et al.
Published: (2023-03-01) -
Audio-Vestibular Manifestations in COVID-19; A Systematic Review and Meta-analysis
by: Saikat Samaddar, et al.
Published: (2023-03-01)